(Q45111292)

9 December 2017

title

Atorvastatin effect on high-density lipoprotein-associated paraoxonase activity and oxidative DNA damage (English)

1 reference

9 December 2017

1 reference

1

1 reference

9 December 2017

Ildikó Seres

2

1 reference

9 December 2017

Zsuzsa Varga

3

1 reference

9 December 2017

Gabriella Emri

4

1 reference

9 December 2017

Zoltán Szilvássy

5

1 reference

9 December 2017

György Paragh

6

1 reference

9 December 2017

Eva Remenyik

7

1 reference

9 December 2017

publication date

14 October 2004

1 reference

European Journal of Clinical Pharmacology

9 December 2017

published in

1 reference

9 December 2017

volume

60

1 reference

9 December 2017

issue

10

1 reference

9 December 2017

page(s)

685-691

1 reference

https://scigraph.springernature.com/pub.10.1007/s00228-004-0820-6

9 December 2017

exact match

0 references

cites work

Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics

1 reference

https://api.crossref.org/works/10.1007%2FS00228-004-0820-6

Interaction of lipid peroxidation products with DNA. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-004-0820-6

Human serum Paraoxonase/Arylesterase's retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids : apolipoprotein A-I stabilizes activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-004-0820-6

Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-004-0820-6

Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity

21 January 2018

1 reference

12 December 2020

Hypolipidemic drugs reduce lipoprotein susceptibility to undergo lipid peroxidation: in vitro and ex vivo studies

1 reference

12 December 2020

Multiple-dose pharmacokinetics, pharmacodynamics, and safety of atorvastatin, an inhibitor of HMG-CoA reductase, in healthy subjects

1 reference

12 December 2020

Lovastatin inhibits low-density lipoprotein oxidation and alters its fluidity and uptake by macrophages: in vitro and in vivo studies

1 reference

12 December 2020

Effects of atorvastatin treatment on the oxidatively modified low density lipoprotein in hyperlipidemic patients

1 reference

12 December 2020

Statins promote potent systemic antioxidant effects through specific inflammatory pathways

1 reference

12 December 2020

A comparative study of the in vitro antioxidant activity of statins

1 reference

12 December 2020

Is paraoxonase related to atherosclerosis

1 reference

12 December 2020

Lipid and apolipoprotein levels and distribution in patients with hypertriglyceridemia: effect of triglyceride reductions with atorvastatin

1 reference

12 December 2020

Ciprofibrate treatment in patients with atherogenic lipoprotein phenotype: effects on HDL quality, LDL susceptibility to oxidation and DNA damage

1 reference

12 December 2020

Effect of inhibiting HMG-CoA reductase on 7 alpha-hydroxy-4-cholesten-3-one, a marker of bile acid synthesis: contrasting findings in patients with and without prior up-regulation of the latter pathway

1 reference

12 December 2020

Nitric Oxide Inhibition of Lipid Peroxidation: Kinetics of Reaction with Lipid Peroxyl Radicals and Comparison with α-Tocopherol†

1 reference

12 December 2020

Atorvastatin and gemfibrozil metabolites, but not the parent drugs, are potent antioxidants against lipoprotein oxidation

1 reference

12 December 2020

LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture

1 reference

12 December 2020

Altered signal pathway in granulocytes from patients with hypercholesterolemia

1 reference

12 December 2020

Serum Paraoxonase Activity Changes in Uremic and Kidney-Transplanted Patients

1 reference

12 December 2020

Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g

1 reference

12 December 2020

Action of atorvastatin in combined hyperlipidemia : preferential reduction of cholesteryl ester transfer from HDL to VLDL1 particles

1 reference

12 December 2020

Effect of atorvastatin on blood lipid levels in the first 2 weeks of treatment: a randomized, placebo-controlled study

1 reference

12 December 2020

Comparison of therapy with simvastatin 80 mg and atorvastatin 80 mg in patients with familial hypercholesterolaemia.

1 reference

12 December 2020

[Evaluating the efficacy and tolerance of atorvastatin in hyperlipidemia in general practice (SWITCH Study)]

1 reference

12 December 2020

The serum paraoxonase activity in patients with chronic renal failure and hyperlipidemia

1 reference

12 December 2020

Ultrasensitive and specific detection methods for exocylic DNA adducts: markers for lipid peroxidation and oxidative stress

1 reference

12 December 2020

Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein

1 reference

12 December 2020

Apolipoprotein J is associated with paraoxonase in human plasma

1 reference

12 December 2020

Effect of simvastatin therapy on paraoxonase activity and related lipoproteins in familial hypercholesterolemic patients

1 reference

12 December 2020

Interaction of oxidized low density lipoprotein with macrophages in atherosclerosis, and the antiatherogenicity of antioxidants.

1 reference

12 December 2020

Effects of human low-density lipoproteins on superoxide production by formyl-methionyl-leucyl-phenylalanine activated polymorphonuclear leukocytes

1 reference

12 December 2020

Comparative efficacy study of atorvastatin vs simvastatin, pravastatin, lovastatin and placebo in type 2 diabetic patients with hypercholesterolaemia

1 reference

12 December 2020

Determination of DNA damage induced by oxidative stress in hyperlipidemic patients

1 reference

12 December 2020

High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein

1 reference

12 December 2020

The protective role of high-density lipoprotein on oxidized-low-density-lipoprotein-induced U937/endothelial cell interactions

1 reference

12 December 2020

Comparison of efficacy and safety of atorvastatin (10mg) with simvastatin (10mg) at six weeks. ASSET Investigators

1 reference

12 December 2020

Scavenging, signalling and adhesion coupling in macrophages: implications for atherogenesis.

1 reference

12 December 2020

Antioxidative effects of fluvastatin and its metabolites against oxidative DNA damage in mammalian cultured cells

1 reference

12 December 2020

10.1007/S00228-004-0820-6

Identifiers

DOI

1 reference

Dimensions Publication ID

9 December 2017

1045078231

0 references

1 reference